Phosphodiesterase inhibitors

Mechanism of Action - cAMP/cGMP Boosters

• Phosphodiesterases (PDEs) are enzymes that degrade cyclic nucleotides (cAMP & cGMP), terminating their intracellular signals.
• PDE inhibitors prevent this breakdown, leading to ↑ intracellular levels of cAMP and/or cGMP.
  • cAMP Boost: Activates Protein Kinase A (PKA) → ↑ cardiac contractility & smooth muscle relaxation (vasodilation).
  • cGMP Boost: Activates Protein Kinase G (PKG) → smooth muscle relaxation (vasodilation).

⭐ Different PDE isoenzymes are tissue-specific. PDE3 is prominent in cardiac and smooth muscle, while PDE5 is concentrated in the corpus cavernosum and pulmonary vasculature, explaining the targeted effects of different inhibitor drugs.

PDE Subtypes & Drugs - The Selective Blockers

• PDE3 Inhibitors: Inodilators

  • Milrinone, Inamrinone: Used in acute decompensated heart failure (↑ contractility, ↓ afterload).
  • Cilostazol: Treats intermittent claudication by causing arterial vasodilation.
    • ⚠️ Contraindicated in heart failure.

• PDE4 Inhibitors: Anti-inflammatory

  • Roflumilast: Reduces exacerbations in severe COPD.
  • Apremilast: Used for psoriatic arthritis and plaque psoriasis.

• PDE5 Inhibitors: Vasodilators (cGMP-specific)

  • Sildenafil, Tadalafil, Vardenafil: Treat erectile dysfunction & pulmonary hypertension.
  • 📌 "-afils" will fill the corpus cavernosum.
  • ⚠️ Avoid with nitrates (risk of severe hypotension).

⭐ Sildenafil can cause cyanopsia (blue-tinted vision) due to weak inhibition of PDE6 in the retina.

Clinical Use & Dangers - Heart, Lungs, & More

• Heart Failure (Acute Decompensated)

  • Milrinone (PDE3-I): ↑ cAMP in cardiac/smooth muscle → inotropy & vasodilation (inodilator).
  • ⚠️ Dangers: Ventricular arrhythmias, hypotension, thrombocytopenia.

• Lungs (Asthma/COPD)

  • Theophylline (Non-selective): Bronchodilation; limited by narrow therapeutic index.
  • ⚠️ Dangers: Cardiotoxicity (arrhythmias), neurotoxicity (seizures).
  • Roflumilast (PDE4-I): Reduces inflammation in severe COPD.

• Erectile Dysfunction & Pulmonary Arterial Hypertension (PAH)

  • Sildenafil, Tadalafil (PDE5-I): ↑ cGMP → prolonged smooth muscle relaxation.
  • ⚠️ Dangers: Hypotension, flushing, headache, cyanopsia (blue-tinted vision).

⭐ Co-administration of nitrates and PDE5 inhibitors is strictly contraindicated. The combination can cause synergistic and life-threatening hypotension.

High‑Yield Points - ⚡ Biggest Takeaways

• PDE inhibitors work by increasing intracellular cAMP and/or cGMP, leading to increased cardiac contractility and smooth muscle relaxation.
• Milrinone (PDE3 inhibitor) is a key inotrope for acute decompensated heart failure; major side effects are arrhythmias and hypotension.
• Sildenafil and Tadalafil (PDE5 inhibitors) cause vasodilation, treating erectile dysfunction and pulmonary hypertension.
• Side effects of PDE5 inhibitors include hypotension, flushing, headache, and cyanopsia (blue vision).
• Contraindicated with nitrates due to risk of severe, life-threatening hypotension.